Half-year report · HY
6062.TEDINET S100XJIE
Period2025-07-01 → 2025-12-31
Filed2026-02-05
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 47
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥22.3bn | 2025-07-01 → 2025-12-31 | Cons. | Net sales |
| Revenue | ¥46.7bn | 2024-07-01 → 2025-06-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥20.1bn | 2024-07-01 → 2024-12-31 | Cons. | Net sales |
| Operating income | ¥2.4bn | 2025-07-01 → 2025-12-31 | Cons. | Operating income |
| Operating income | ¥1.8bn | 2024-07-01 → 2024-12-31 | Cons. | Operating income |
| Ordinary income | ¥2.5bn | 2025-07-01 → 2025-12-31 | Cons. | Ordinary income |
| Ordinary income | ¥4.0bn | 2024-07-01 → 2025-06-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥1.9bn | 2024-07-01 → 2024-12-31 | Cons. | Ordinary income |
| Profit before tax | ¥2.5bn | 2025-07-01 → 2025-12-31 | Cons. | Income before income taxes |
| Profit before tax | ¥1.9bn | 2024-07-01 → 2024-12-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥1.6bn | 2025-07-01 → 2025-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥2.9bn | 2024-07-01 → 2025-06-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥1.3bn | 2024-07-01 → 2024-12-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥1.6bn | 2025-07-01 → 2025-12-31 | Cons. | Profit loss |
| Net income | ¥1.3bn | 2024-07-01 → 2024-12-31 | Cons. | Profit loss |
| Total assets | ¥53.2bn | at 2025-12-31 | Cons. | Assets |
| Total assets | ¥52.4bn | at 2025-06-30 | Cons. | Assets |
| Total assets | ¥53.0bn | at 2024-12-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥31.8bn | at 2025-12-31 | Cons. | Liabilities |
| Total liabilities | ¥31.7bn | at 2025-06-30 | Cons. | Liabilities |
| Net assets / equity | ¥21.4bn | at 2025-12-31 | Cons. | Net assets |
| Net assets / equity | ¥20.7bn | at 2025-06-30 | Cons. | Net assets |
| Net assets / equity | ¥19.0bn | at 2024-12-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥7.6bn | at 2025-12-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥9.1bn | at 2025-06-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥7.6bn | at 2025-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥9.1bn | at 2025-06-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥7.3bn | at 2024-12-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥12.6bn | at 2024-06-30v | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥2.4bn | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥3.7bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥2.0bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥2.2bn | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥8.5bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥6.4bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥1.7bn | 2025-07-01 → 2025-12-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | ¥1.3bn | 2024-07-01 → 2025-06-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | ¥3.0bn | 2024-07-01 → 2024-12-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥50.41 | 2025-07-01 → 2025-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥89.89 | 2024-07-01 → 2025-06-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥38.93 | 2024-07-01 → 2024-12-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥50.34 | 2025-07-01 → 2025-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥89.77 | 2024-07-01 → 2025-06-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥38.88 | 2024-07-01 → 2024-12-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 40.1% | at 2025-12-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 39.4% | at 2025-06-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.8% | at 2024-12-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 28
| Segment | Item | Period | Value |
|---|---|---|---|
| Otherother segments | revenue | 2025-07-01 → 2025-12-31 | ¥1.3bn |
| Otherother segments | revenue external | 2025-07-01 → 2025-12-31 | ¥990m |
| Otherother segments | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥324m |
| Otherother segments | segment profit | 2025-07-01 → 2025-12-31 | ¥23m |
| Reconciling Itemsreconciling | revenue | 2025-07-01 → 2025-12-31 | −¥324m |
| Reconciling Itemsreconciling | revenue intersegment | 2025-07-01 → 2025-12-31 | −¥324m |
| Reconciling Itemsreconciling | segment profit | 2025-07-01 → 2025-12-31 | −¥617m |
| Nursing Carereportable segment | revenue | 2025-07-01 → 2025-12-31 | ¥21.3bn |
| Nursing Carereportable segment | revenue external | 2025-07-01 → 2025-12-31 | ¥21.3bn |
| Nursing Carereportable segment | segment profit | 2025-07-01 → 2025-12-31 | ¥3.0bn |
| —segment total | revenue | 2025-07-01 → 2025-12-31 | ¥22.7bn |
| —segment total | revenue external | 2025-07-01 → 2025-12-31 | ¥22.3bn |
| —segment total | revenue intersegment | 2025-07-01 → 2025-12-31 | ¥324m |
| —segment total | segment profit | 2025-07-01 → 2025-12-31 | ¥3.0bn |
| Otherother segments | revenue | 2024-07-01 → 2024-12-31 | ¥1.4bn |
| Otherother segments | revenue external | 2024-07-01 → 2024-12-31 | ¥1.1bn |
| Otherother segments | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥302m |
| Otherother segments | segment profit | 2024-07-01 → 2024-12-31 | −¥1m |
| Reconciling Itemsreconciling | revenue | 2024-07-01 → 2024-12-31 | −¥302m |
| Reconciling Itemsreconciling | revenue intersegment | 2024-07-01 → 2024-12-31 | −¥302m |
| Reconciling Itemsreconciling | segment profit | 2024-07-01 → 2024-12-31 | −¥623m |
| Nursing Carereportable segment | revenue | 2024-07-01 → 2024-12-31 | ¥18.9bn |
| Nursing Carereportable segment | revenue external | 2024-07-01 → 2024-12-31 | ¥18.9bn |
| Nursing Carereportable segment | segment profit | 2024-07-01 → 2024-12-31 | ¥2.4bn |
| —segment total | revenue | 2024-07-01 → 2024-12-31 | ¥20.4bn |
| —segment total | revenue external | 2024-07-01 → 2024-12-31 | ¥20.1bn |
| —segment total | revenue intersegment | 2024-07-01 → 2024-12-31 | ¥302m |
| —segment total | segment profit | 2024-07-01 → 2024-12-31 | ¥2.4bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 491
| Item | Context | Value | Unit |
|---|---|---|---|
| Number of shares held | InterimInstant_No2MajorShareholdersMember | 5308600 | |
| Shareholding ratio | InterimInstant_No2MajorShareholdersMember | 0.1624 | |
| Number of shares held | InterimInstant_No3MajorShareholdersMember | 2226800 | |
| Shareholding ratio | InterimInstant_No3MajorShareholdersMember | 0.0681 | |
| Number of shares held | InterimInstant_No4MajorShareholdersMember | 963246 | |
| Shareholding ratio | InterimInstant_No4MajorShareholdersMember | 0.0295 | |
| Number of shares held | InterimInstant_No5MajorShareholdersMember | 917100 | |
| Shareholding ratio | InterimInstant_No5MajorShareholdersMember | 0.0281 | |
| Number of shares held | InterimInstant_No6MajorShareholdersMember | 617070 | |
| Shareholding ratio | InterimInstant_No6MajorShareholdersMember | 0.0189 | |
| Number of shares held | InterimInstant_No7MajorShareholdersMember | 491900 | |
| Shareholding ratio | InterimInstant_No7MajorShareholdersMember | 0.0151 | |
| Number of shares held | InterimInstant_No8MajorShareholdersMember | 396500 | |
| Shareholding ratio | InterimInstant_No8MajorShareholdersMember | 0.0121 | |
| Number of shares held | InterimInstant_No9MajorShareholdersMember | 375000 | |
| Shareholding ratio | InterimInstant_No9MajorShareholdersMember | 0.0115 | |
| Number of shares held | InterimInstant_No10MajorShareholdersMember | 368200 | |
| Shareholding ratio | InterimInstant_No10MajorShareholdersMember | 0.0113 | |
| Number of shares held | InterimInstant | 21264416 | |
| Shareholding ratio | InterimInstant | 0.6507 | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithNoVotingRightsMember | － | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsTreasurySharesEtcMember | － | |
| Number of shares issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of voting rights issued shares voting rights | InterimInstant_SharesWithRestrictedVotingRightsOtherMember | － | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsTreasurySharesEtcMember | 30600 | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 32660300 | |
| Number of voting rights issued shares voting rights | InterimInstant_OrdinarySharesSharesWithFullVotingRightsOtherMember | 326603 | |
| Number of shares issued shares voting rights | InterimInstant_OrdinarySharesSharesLessThanOneUnitMember | 21100 | |
| Number of shares issued shares voting rights | InterimInstant | 32712000 | |
| Number of voting rights issued shares voting rights | InterimInstant | 326603 | |
| Number of shares held in own name treasury shares etc | InterimInstant_Row1Member | 30600 | |
| Number of shares held in others names treasury shares etc | InterimInstant_Row1Member | － | |
| Total number of shares held treasury shares etc | InterimInstant_Row1Member | 30600 | |
| Shareholding ratio treasury shares etc | InterimInstant_Row1Member | 0.0009 | |
| Number of shares held in own name treasury shares etc | InterimInstant | 30600 | |
| Number of shares held in others names treasury shares etc | InterimInstant | － | |
| Total number of shares held treasury shares etc | InterimInstant | 30600 | |
| Shareholding ratio treasury shares etc | InterimInstant | 0.0009 | |
| Cash and deposits | Prior1YearInstant | 9149000000 | JPY |
| Cash and deposits | InterimInstant | 7629000000 | JPY |
| Accounts receivable trade | Prior1YearInstant | 3763000000 | JPY |
| Accounts receivable trade | InterimInstant | 3979000000 | JPY |
| Real estate for development ca | Prior1YearInstant | 1609000000 | JPY |
| Real estate for development ca | InterimInstant | 2114000000 | JPY |
| Money held in trust ca | Prior1YearInstant | 6274000000 | JPY |
| Money held in trust ca | InterimInstant | 6318000000 | JPY |
| Other ca | Prior1YearInstant | 1116000000 | JPY |
| Other ca | InterimInstant | 1043000000 | JPY |
| Allowance for doubtful accounts ca | Prior1YearInstant | -8000000 | JPY |
| Allowance for doubtful accounts ca | InterimInstant | -8000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |